2j14
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==3,4,5-Trisubstituted Isoxazoles as Novel PPARdelta Agonists: Part2== | ==3,4,5-Trisubstituted Isoxazoles as Novel PPARdelta Agonists: Part2== | ||
| - | <StructureSection load='2j14' size='340' side='right' caption='[[2j14]], [[Resolution|resolution]] 2.80Å' scene=''> | + | <StructureSection load='2j14' size='340' side='right'caption='[[2j14]], [[Resolution|resolution]] 2.80Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[2j14]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2J14 OCA]. For a <b>guided tour on the structure components</b> use [http:// | + | <table><tr><td colspan='2'>[[2j14]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2J14 OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=2J14 FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GNI:(3-{4-[2-(2,4-DICHLORO-PHENOXY)-ETHYLCARBAMOYL]-5-PHENYL-ISOXAZOL-3-YL}-PHENYL)-ACETIC+ACID'>GNI</scene></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GNI:(3-{4-[2-(2,4-DICHLORO-PHENOXY)-ETHYLCARBAMOYL]-5-PHENYL-ISOXAZOL-3-YL}-PHENYL)-ACETIC+ACID'>GNI</scene></td></tr> |
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1gwx|1gwx]], [[1y0s|1y0s]], [[2awh|2awh]], [[2b50|2b50]], [[2baw|2baw]], [[2gwx|2gwx]], [[3gwx|3gwx]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1gwx|1gwx]], [[1y0s|1y0s]], [[2awh|2awh]], [[2b50|2b50]], [[2baw|2baw]], [[2gwx|2gwx]], [[3gwx|3gwx]]</td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http:// | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=2j14 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2j14 OCA], [http://pdbe.org/2j14 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=2j14 RCSB], [http://www.ebi.ac.uk/pdbsum/2j14 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=2j14 ProSAT]</span></td></tr> |
</table> | </table> | ||
== Evolutionary Conservation == | == Evolutionary Conservation == | ||
| Line 29: | Line 29: | ||
==See Also== | ==See Also== | ||
| - | *[[ | + | *[[Phenylethanolamine N-methyltransferase 3D structures|Phenylethanolamine N-methyltransferase 3D structures]] |
== References == | == References == | ||
<references/> | <references/> | ||
| Line 35: | Line 35: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | [[Category: Human]] | ||
| + | [[Category: Large Structures]] | ||
[[Category: Azimioara, M]] | [[Category: Azimioara, M]] | ||
[[Category: Bursulaya, B]] | [[Category: Bursulaya, B]] | ||
Revision as of 07:36, 15 April 2020
3,4,5-Trisubstituted Isoxazoles as Novel PPARdelta Agonists: Part2
| |||||||||||
Categories: Human | Large Structures | Azimioara, M | Bursulaya, B | Cow, C | Epple, R | Gerken, A | Iskandar, M | Karanewsky, D | Kreusch, A | Russo, R | Saez, E | Seidel, H M | Tian, S S | Tuntland, T | Wang, X | Wityak, J | Xie, Y | Activator | Alternative splicing | Dna-binding | Fatty acid | Metal-binding | Nuclear protein | Nuclear receptor fold | Ppar | Receptor | Transcription | Transcription regulation | Zinc | Zinc-finger
